EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge

Liana Nunes Barbosa iD, Alejandro LIanes, Swetha Madesh, Bryanna Nicole Fayne, Kalvis Brangulis, Sarah C Linn-Peirano, Sreekumari Rajeev iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Liana Nunes Barbosa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, United States of Ame…. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Bacterial Vaccines, Leptospira, Leptospirosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptospirosis is the most widespread zoonosis and a life-threatening disease in humans and animals. Licensed killed whole-cell vaccines are available for animals; however, they do not offer heterologous protection, do not induce long-term protection, or prevent renal colonization. In this study, we characterized an immunogenic Leptospira methyl-accepting chemotaxis protein (MCP) identified through a reverse vaccinology approach, predicted its structure, and tested the protective efficacy of a recombinant MCP fragment in the C3H/HeJ mice model. The predicted structure of the full-length MCP revealed an architecture typical for topology class I MCPs. A single dose of MCP vaccine elicited a significant IgG antibody response in immunized mice compared to controls ( P < 0.0001), especially the IgG1 and IgG2a subclasses. The vaccination with MCP, despite eliciting a robust immune response, did not protect mice from disease and renal colonization. However, survival curves significantly differed between groups, and the MCP-vaccinated group developed clinical signs faster than the control group. There were differences in gross and histopathological changes between the MCP-vaccinated and control groups. The factors leading to enhanced disease process in vaccinated animals need further investigation. We speculate that anti-MCP antibodies may block the MCP signaling cascade and may limit chemotaxis, preventing Leptospira from reaching its destination, but facilitating its maintenance and replication in the blood stream. Such a phenomenon may exist in endemic areas where humans are highly exposed to Leptospira antigens, and the presence of antibodies might lead to disease enhancement. The role of this protein in Leptospira pathogenesis should be further evaluated to comprehend the lack of protection and potential exacerbation of the disease process. The absence of immune correlates of protection from Leptospira infection is still a major limitation of this field and efforts to gather this knowledge are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BacterialBacterial VaccinesLeptospiraLeptospirosisAnimalsFemaleMiceBacterial ProteinsChemotaxisDisease Models, AnimalImmunoglobulin GMice, Inbred C3HVaccination

Substanzen

Antibodies, BacterialBacterial ProteinsBacterial VaccinesImmunoglobulin G

Autor:innen und Institutionen

  • Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, United States of America.
  • Centro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama City, Panama.
  • Latvian Biomedical Research and Study Centre, Riga, Latvia.

ORCID-Profile: Liana Nunes Barbosa, Sreekumari Rajeev

Zitieren

APA

Barbosa, L. N., LIanes, A., Madesh, S., Fayne, B. N., Brangulis, K., Linn-Peirano, S. C., & Rajeev, S. (2024). Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012155

Vancouver

Barbosa LN, LIanes A, Madesh S, Fayne BN, Brangulis K, Linn-Peirano SC, et al. Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012155

BibTeX
@article{Barbosa2024,
  author = {Barbosa, Liana Nunes and LIanes, Alejandro and Madesh, Swetha and Fayne, Bryanna Nicole and Brangulis, Kalvis and Linn-Peirano, Sarah C and Rajeev, Sreekumari},
  title = {Enhancement of clinical signs in C3H/HeJ mice vaccinated with a highly immunogenic Leptospira methyl-accepting chemotaxis protein following challenge},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012155}
}
Kostenlos starten →